Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 11 Mar 2011
At a glance
- Drugs Trastuzumab; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 11 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2007 New trial record.